SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-11-016495
Filing Date
2011-05-16
Accepted
2011-05-16 18:15:42
Documents
1
Period of Report
2011-05-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3773
  Complete submission text file 0001127602-11-016495.txt   5109
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 667 MADISON AVE 17TH FLOOR NEW YORK NY 10021
Business Address
Biggar Stephen R (Reporting) CIK: 0001340380 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 11849166